Obligatory role of inducible nitric oxide synthase in ischemic preconditioning - PubMed (original) (raw)
Obligatory role of inducible nitric oxide synthase in ischemic preconditioning
Sunghee Cho et al. J Cereb Blood Flow Metab. 2005 Apr.
Abstract
Sublethal insults can induce a transient tolerance toward subsequent lethal ischemia, a phenomenon termed ischemic preconditioning (IPC). In the myocardium, nitric oxide derived from 'inducible' nitric oxide synthase (iNOS or NOS II) plays a critical role in the expression of IPC produced by sublethal ischemia. Here, we investigated whether iNOS is involved in IPC in brain. Ischemic preconditioning was produced in mice by three episodes of 1-min bilateral common carotid artery (BCCA) occlusion, each followed by 5 mins of reperfusion. After 24 h, mice underwent middle cerebral artery (MCA) occlusion for 20 mins. Intraischemic cerebral blood flow was monitored during both in BCCA and MCA occlusion (MCAO) by laser-Doppler flowmetry. Mice were killed 3 days after MCAO, and infarct volume was determined in thionine-stained sections. Infarct volume was significantly reduced 24 h after IPC (70%; P<0.05). Treatment with the iNOS inhibitor aminoguanidine (400 mg/kg), abolished the IPC-induced protection. Furthermore, IPC failed to induce ischemic tolerance in iNOS-null mice. In wild-type mice, IPC increased the resistance to Ca(2+)-mediated depolarization in isolated brain mitochondria. However, in iNOS-null mice IPC failed to induce such resistance. We conclude that iNOS is required for the full expression of IPC and that such effect is coupled to an increased resistance of mitochondria to injury. Thus, iNOS-derived nitric oxide, in addition to its deleterious effects on the late stages of ischemic brain damage, can also be beneficial by promoting ischemic tolerance through signaling, ultimately resulting in mitochondrial protection.
Similar articles
- iNOS-derived NO and nox2-derived superoxide confer tolerance to excitotoxic brain injury through peroxynitrite.
Kawano T, Kunz A, Abe T, Girouard H, Anrather J, Zhou P, Iadecola C. Kawano T, et al. J Cereb Blood Flow Metab. 2007 Aug;27(8):1453-62. doi: 10.1038/sj.jcbfm.9600449. Epub 2007 Feb 7. J Cereb Blood Flow Metab. 2007. PMID: 17293848 - Toll-like receptor 4 is involved in neuroprotection afforded by ischemic preconditioning.
Pradillo JM, Fernández-López D, García-Yébenes I, Sobrado M, Hurtado O, Moro MA, Lizasoain I. Pradillo JM, et al. J Neurochem. 2009 Apr;109(1):287-94. doi: 10.1111/j.1471-4159.2009.05972.x. Epub 2009 Feb 7. J Neurochem. 2009. PMID: 19200341 - Age-dependent increase in ischemic brain injury in wild-type mice and in mice lacking the inducible nitric oxide synthase gene.
Nagayama M, Aber T, Nagayama T, Ross ME, Iadecola C. Nagayama M, et al. J Cereb Blood Flow Metab. 1999 Jun;19(6):661-6. doi: 10.1097/00004647-199906000-00009. J Cereb Blood Flow Metab. 1999. PMID: 10366196 - Nitric oxide-dependent mechanism of anti-ischemic myocardial protection induced by monophosphoryl lipid A.
Xi L. Xi L. Zhongguo Yao Li Xue Bao. 1999 Oct;20(10):865-71. Zhongguo Yao Li Xue Bao. 1999. PMID: 11270982 Review. - Nitric oxide and cerebral ischemic preconditioning.
Huang PL. Huang PL. Cell Calcium. 2004 Sep-Oct;36(3-4):323-9. doi: 10.1016/j.ceca.2004.02.007. Cell Calcium. 2004. PMID: 15261488 Review.
Cited by
- The Impact of Remote Ischemic Preconditioning on Arterial Stiffness and Heart Rate Variability in Patients with Angina Pectoris.
Zagidullin N, Scherbakova E, Safina Y, Zulkarneev R, Zagidullin S. Zagidullin N, et al. J Clin Med. 2016 Jun 23;5(7):60. doi: 10.3390/jcm5070060. J Clin Med. 2016. PMID: 27348009 Free PMC article. - Novel Cellular Mechanisms for Neuroprotection in Ischemic Preconditioning: A View from Inside Organelles.
Sisalli MJ, Annunziato L, Scorziello A. Sisalli MJ, et al. Front Neurol. 2015 May 26;6:115. doi: 10.3389/fneur.2015.00115. eCollection 2015. Front Neurol. 2015. PMID: 26074868 Free PMC article. Review. - Role of Nitric Oxide in Neurodegeneration: Function, Regulation, and Inhibition.
Tewari D, Sah AN, Bawari S, Nabavi SF, Dehpour AR, Shirooie S, Braidy N, Fiebich BL, Vacca RA, Nabavi SM. Tewari D, et al. Curr Neuropharmacol. 2021;19(2):114-126. doi: 10.2174/1570159X18666200429001549. Curr Neuropharmacol. 2021. PMID: 32348225 Free PMC article. Review. - Subcellular Energetics and Metabolism: Potential Therapeutic Applications.
Thiele RH. Thiele RH. Anesth Analg. 2017 Jun;124(6):1872-1885. doi: 10.1213/ANE.0000000000001865. Anesth Analg. 2017. PMID: 28277320 Free PMC article. Review. - Prohibitin reduces mitochondrial free radical production and protects brain cells from different injury modalities.
Zhou P, Qian L, D'Aurelio M, Cho S, Wang G, Manfredi G, Pickel V, Iadecola C. Zhou P, et al. J Neurosci. 2012 Jan 11;32(2):583-92. doi: 10.1523/JNEUROSCI.2849-11.2012. J Neurosci. 2012. PMID: 22238093 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous